Koizumi G, Hayashi A, Takigawa A, Yamada R, Murata T, Shimizu K
J Investig Med High Impact Case Rep. 2024; 12:23247096241258076.
PMID: 38818904
PMC: 11143842.
DOI: 10.1177/23247096241258076.
Reinert C, Pfannenberg C, Guckel B, Dittmann H, Fougere C, Nikolaou K
Diagnostics (Basel). 2024; 14(4).
PMID: 38396467
PMC: 10888075.
DOI: 10.3390/diagnostics14040428.
Jiang A, Zhang Z, Qiu X, Guo Q
Arch Toxicol. 2023; 98(3):689-708.
PMID: 38155341
DOI: 10.1007/s00204-023-03653-7.
Taguchi A, Tanaka S, Ozaki T, Arai K, Mori S, Ohta H
J Bone Miner Metab. 2023; 41(6):854-864.
PMID: 37897672
DOI: 10.1007/s00774-023-01466-3.
Taguchi A, Hagino H, Inoue D, Endo N, Society J
J Bone Miner Metab. 2023; 41(6):829-837.
PMID: 37516668
DOI: 10.1007/s00774-023-01458-3.
Medication-Related Osteonecrosis of the Jaws: A Comparison of SICMF-SIPMO and AAOMS Guidelines.
De Cicco D, Emiliano Boschetti C, Santagata M, Colella G, Stagliano S, Gaggl A
Diagnostics (Basel). 2023; 13(13).
PMID: 37443531
PMC: 10340476.
DOI: 10.3390/diagnostics13132137.
Comparison of Different Antibiotic Regimes for Preventive Tooth Extractions in Patients with Antiresorptive Intake-A Retrospective Cohort Study.
Ristow O, Ruckschloss T, Schnug G, Moratin J, Bleymehl M, Zittel S
Antibiotics (Basel). 2023; 12(6).
PMID: 37370316
PMC: 10295042.
DOI: 10.3390/antibiotics12060997.
Novel modified quantitative index for cone-beam CT assessment of medication-related osteonecrosis of the jaw - comparative analysis with original index.
Badabaan G, Strickland M, Singer S, Creanga A, Subramanian G
Saudi Dent J. 2023; 35(4):310-316.
PMID: 37251718
PMC: 10213865.
DOI: 10.1016/j.sdentj.2023.03.003.
Clinical and Histopathological Aspects of MRONJ in Cancer Patients.
Ciobanu G, Mogoanta L, Camen A, Ionescu M, Vlad D, Staicu I
J Clin Med. 2023; 12(10).
PMID: 37240491
PMC: 10219482.
DOI: 10.3390/jcm12103383.
Quantitative indices for cone-beam CT assessment of Medication-Related Osteonecrosis of the Jaw - a scoping review.
Badabaan G, Creanga A, Singer S, Strickland M, Subramanian G
Saudi Dent J. 2023; 35(2):133-140.
PMID: 36942207
PMC: 10024109.
DOI: 10.1016/j.sdentj.2022.12.012.
Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Terms of Staging and Treatment Strategies by Dental Students at Different Educational Levels.
Heimes D, Mark N, Kuchen R, Pabst A, Becker P, Kyyak S
Medicina (Kaunas). 2023; 59(2).
PMID: 36837455
PMC: 9962432.
DOI: 10.3390/medicina59020252.
Dietary nitrate improves jaw bone remodelling in zoledronate-treated mice.
Pan W, Gu J, Xu S, Zhang C, Wang J, Wang S
Cell Prolif. 2023; 56(7):e13395.
PMID: 36810909
PMC: 10334281.
DOI: 10.1111/cpr.13395.
Correlation of dynamic contrast-enhanced bone perfusion with morphologic ultra-short echo time MR imaging in medication-related osteonecrosis of the jaw.
Schumann P, Morgenroth S, Huber F, Rupp N, Del Grande F, Guggenberger R
Dentomaxillofac Radiol. 2021; 51(2):20210036.
PMID: 34406841
PMC: 8802699.
DOI: 10.1259/dmfr.20210036.
F-Fluoride PET/CT Imaging of Medication-Related Osteonecrosis of the Jaw in Conservative Treatment-A Case Report.
Reinert C, Pfannenberg C, Gatidis S, Fougere C, Nikolaou K, Hoefert S
Front Oncol. 2021; 11:700397.
PMID: 34277447
PMC: 8281890.
DOI: 10.3389/fonc.2021.700397.
Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches.
On S, Cho S, Byun S, Yang B
Antioxidants (Basel). 2021; 10(5).
PMID: 33925361
PMC: 8145192.
DOI: 10.3390/antiox10050680.
Use and Evaluation of a Computer-Assisted Examination Method for the Diagnosis and Analysis of Medication-Related Osteonecrosis of the Jaw.
Wilkat M, Singh D, Lutz I, Mollmann H, Gellrich N, Rana M
Craniomaxillofac Trauma Reconstr. 2021; 14(1):36-42.
PMID: 33613834
PMC: 7868509.
DOI: 10.1177/1943387520922767.
Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.
Wongratwanich P, Shimabukuro K, Konishi M, Nagasaki T, Ohtsuka M, Suei Y
Dentomaxillofac Radiol. 2021; 50(6):20200417.
PMID: 33411572
PMC: 8404513.
DOI: 10.1259/dmfr.20200417.
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020.
Campisi G, Mauceri R, Bertoldo F, Bettini G, Biasotto M, Colella G
Int J Environ Res Public Health. 2020; 17(16).
PMID: 32824826
PMC: 7460511.
DOI: 10.3390/ijerph17165998.
Skeletal Site-Specific Response of Jawbones and Long Bones to Surgical Interventions in Rats Treated with Zoledronic Acid.
Wang J, Huo L, Yu R, Rao N, Lu W, Zheng L
Biomed Res Int. 2020; 2019:5138175.
PMID: 31930124
PMC: 6942746.
DOI: 10.1155/2019/5138175.
From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights.
Anesi A, Generali L, Sandoni L, Pozzi S, Grande A
Int J Mol Sci. 2019; 20(19).
PMID: 31590328
PMC: 6801843.
DOI: 10.3390/ijms20194925.